title: Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic haemodialysis: a real clinical entity?
authors.forename: D C
authors.initials: DC
authors.lastname: Tarng
authors.forename: T P
authors.initials: TP
authors.lastname: Huang
authors.forename: T W
authors.initials: TW
authors.lastname: Chen
authors.forename: C Y
authors.initials: CY
authors.lastname: Fan
authors.forename: J G
authors.initials: JG
authors.lastname: Chang
mesh_terms: D000328:Adult; D000368:Aged; D004351:Drug Resistance; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000090463:Iron Deficiencies; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*; D013789:Thalassemia / Q000150:complications / Q000188:drug therapy* / Q000628:therapy*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin